Abstract:Abstract Background Maximal hyperemia capacity and myocardial flow reserve (MFR) have emerged as critical indicators of cardiovascular prognosis, with reduced vascular functionality associated with adverse outcomes (1). PET-CT serves as the gold standard for MFR assessment in clinical practice. In recent years, SPECT equipment with high-performance CZT detectors has been utilized for quantitative assessment of coronary flow at rest and under maximal hyperemia. The potential of MFR in guiding clinical decision-making for coronary artery disease (CAD) management is increasingly recognized. However, the clinical feasibility and utility of CZT-derived MFR data remains under active investigation. Objective This study aims to describe the feasibility of quantitatively measuring myocardial flow reserve obtained using SPECT equipment with CZT detectors in patients undergoing scintigraphy to assess coronary disease. Methodology One hundred patients with suspected or known CAD underwent pharmacological stress myocardial perfusion scintigraphy (adenosine) and rest imaging using a D-SPECT device (Spectrum Dynamics) between October 7th, 2021, and December 30th, 2022. Dynamic tomographic images were acquired with the administration of 99mTc-sestamibi via an injection pump (Bracco) at a flow rate of 1 ml/second. Cedars Sinai's QPS kinetic software was used to calculate MFR, with values < 2 considered abnormal. Statistical analysis was performed using a significance level of 5% and the Student's T-type comparison test. Results Twenty patients (71 men), with a mean age of 69.4 years, were evaluated. Thirteen exams presented global MFR < 2, with an additional 11 patients showing global MFR > 2 and regional MFR in any of the three coronary territories below 2. Notably, six patients with MFR < 2 did not demonstrate abnormal myocardial perfusion imaging in SPECT. Patients with MFR values < 2 had a lower mean left ventricular ejection fraction compared to those with MFR > 2 (52% vs. 62%; p = 0.02). All exams were of good quality and interpretable. Motion correction was required in most exams (>90%). In two patients, the radiotracer and adenosine were administered through external jugular venous access due to unavailability of venous access in the cubital fossa. Conclusion Myocardial flow reserve (MFR) assessment can be effectively conducted using SPECT equipment equipped with CZT detectors, enabling the identification of patients with diminished MFR both globally and within specific coronary territories. These findings provide valuable insights into the management of patients with suspected or confirmed coronary artery disease (CAD). However, further investigation is warranted to elucidate the precise clinical implications of MFR assessment with CZT SPECT in guiding management strategies for patients with CAD.

Myocardial perfusion SPECT in Germany from 2012 to 2021: insights into development and quality indicators

Myocardial Perfusion SPECT and ATTR imaging 2021 in Germany: Results of the 9th Survey

Clinical Application of PET Myocardial Perfusion Imaging

Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)

Clinical Application of Myocardial Perfusion SPECT in Patients with Suspected or Known Coronary Artery Disease. What Role in the Multimodality Imaging Era?

State and Recent Progress of Nuclear Cardiology in China

Temporal changes in PET myocardial perfusion imaging over 15 years: patient characteristics and imaging findings

Characterization of myocardial perfusion imaging systems - an extension of quality metrics

Can patient-specific acquisition protocol improve performance on defect detection task in myocardial perfusion SPECT?

Myocardial blood flow evaluation with dynamic cadmium-zinc-telluride single-photon emission computed tomography: Bright and dark sides

Head-to-Head Comparison of CZT-SPECT and SPECT/CT Myocardial Perfusion Imaging: Interobserver and Intraobserver Agreement and Diagnostic Performance

Recent Developments in SPECT/CT

Myocardial perfusion imaging with PET

Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT)

Advances in Myocardial Perfusion MR Imaging: Physiological Implications, the Importance of Quantitative Analysis, and Impact on Patient Care in Coronary Artery Disease

Non-invasive imaging techniques to assess myocardial perfusion

EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision

Assessing myocardial flow reserve using CZT SPECT perfusion imaging: a step towards clinical application

PET-determined myocardial perfusion and flow in coronary artery disease characterization

CT Myocardial Perfusion Imaging: A New Frontier in Cardiac Imaging

Multi-center study of inter-rater reproducibility, image quality, and diagnostic accuracy of CZT versus conventional SPECT myocardial perfusion imaging